Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large-Cell, Anaplastic

Explore clinical trials studying Lymphoma, Large-Cell, Anaplastic. Study availability and eligibility vary by location and protocol.

289 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large-Cell, Anaplastic trial results

Completed

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

NCT02168140

Conditions
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +40 more
Locations
  • Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
  • Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

NCT01606878

Conditions
Childhood Solid Neoplasm, Hemic and Lymphatic Diseases, Immune System Diseases, +19 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
View all 23 locations
View Trial Details
Completed

Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

NCT02561273

Conditions
Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Enteropathy-Associated T-Cell Lymphoma, +21 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
View Trial Details
Completed

CREATE: Cross-tumoral Phase 2 With Crizotinib

NCT01524926

Conditions
Granuloma, Granuloma, Plasma Cell, Hemic and Lymphatic Diseases, +27 more
Locations
  • Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
  • U.Z. Gasthuisberg Leuven, Belgium
  • Institut Bergonie Bordeaux, France
  • Centre Georges-Francois-Leclerc Dijon, France
View all 25 locations
View Trial Details
Completed

Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma

NCT01035463

Conditions
Anaplastic Large Cell Lymphoma, ALK-negative, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • University of Kansas Hospital-Westwood Cancer Center Westwood, Kansas, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Prospective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic Lymphoma

NCT03603847

Conditions
Anaplastic Large Cell Lymphoma, ALK-Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • CHU Amiens - Hôpital Sud Amiens, France
  • CHU d'Estaing Clermont-Ferrand, France
  • APHP - Hopital Henri Mondor Créteil, France
  • CHU Grenoble Grenoble, France
View all 15 locations
View Trial Details
Completed

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

NCT01336933

Conditions
Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations
  • Mayo Clinic, Arizona Scottsdale, Arizona, United States
  • Stanford University Stanford, California, United States
  • Emory University School Of Medicine Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details

Related conditions